Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
CentraCare Heart & Vascular Center
mi
from
Saint Cloud, MN
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
CentraCare Heart & Vascular Center
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
Minneapolis Heart Institute Foundation, Mercy Hospital (Coon Rapids MN), Unity Hospital, United Hospital, Abbott Northwestern Hospital
mi
from
Saint Paul, MN
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
Minneapolis Heart Institute Foundation, Mercy Hospital (Coon Rapids MN), Unity Hospital, United Hospital, Abbott Northwestern Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
Cardiovascular Consultants, P.C., Saint Luke's Hospital, Mid America Heart Institute (MAHI)
mi
from
Kansas City, MO
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
Cardiovascular Consultants, P.C., Saint Luke's Hospital, Mid America Heart Institute (MAHI)
mi
from
Kansas City, MO
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
Hackensack University Medical Center
mi
from
Hackensack, NJ
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
New Mexico Heart Institute
mi
from
Albuquerque, NM
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
New Mexico Heart Institute
mi
from
Albuquerque, NM
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
Duke University Medical Center (DUMC)
mi
from
Durham, NC
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
Duke University Medical Center (DUMC)
mi
from
Durham, NC
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
Forsyth Medical Center, Novant Clinical Research Institute
mi
from
Winston-Salem, NC
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
Forsyth Medical Center, Novant Clinical Research Institute
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
Samaritan Health Services
mi
from
Corvallis, OR
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
Samaritan Health Services
mi
from
Corvallis, OR
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
Oregon Health and Science University
mi
from
Portland, OR
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
University of Pittsburgh Medical Center UPMC Presbyterian
mi
from
Pittsburgh, PA
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
University of Pittsburgh Medical Center UPMC Presbyterian
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated:  10/5/2017
Medanta-The Medicity
mi
from
Haryana,
MIRACLE EF Clinical Study
MIRACLE EF Clinical Study
Status: Enrolling
Updated: 10/5/2017
Medanta-The Medicity
mi
from
Haryana,
Click here to add this to my saved trials
Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest
Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest
Status: Enrolling
Updated:  10/5/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest
Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest
Status: Enrolling
Updated: 10/5/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)
Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)
Status: Enrolling
Updated:  10/9/2017
Emory University Hospital Midtown
mi
from
Atlanta, GA
Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)
Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)
Status: Enrolling
Updated: 10/9/2017
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)
Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)
Status: Enrolling
Updated:  10/9/2017
Emory University Hospital
mi
from
Atlanta, GA
Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)
Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)
Status: Enrolling
Updated: 10/9/2017
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus
A Phase I, Open-Label, Crossover, Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus in Healthy Volunteers
Status: Enrolling
Updated:  10/10/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus
A Phase I, Open-Label, Crossover, Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus in Healthy Volunteers
Status: Enrolling
Updated: 10/10/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation
The Study on Safety and Feasibility of Mitral Loop Cerclage(MLC) Annuloplasty Procedure With Investigational Medical Device (MLC-B-45-75-R and Other 11 Models) : Single-centre, Open Label, Single Arm, Feasibility Test
Status: Enrolling
Updated:  10/11/2017
National Institues of Health
mi
from
Bethesda, MD
Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation
The Study on Safety and Feasibility of Mitral Loop Cerclage(MLC) Annuloplasty Procedure With Investigational Medical Device (MLC-B-45-75-R and Other 11 Models) : Single-centre, Open Label, Single Arm, Feasibility Test
Status: Enrolling
Updated: 10/11/2017
National Institues of Health
mi
from
Bethesda, MD
Click here to add this to my saved trials
Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation
The Study on Safety and Feasibility of Mitral Loop Cerclage(MLC) Annuloplasty Procedure With Investigational Medical Device (MLC-B-45-75-R and Other 11 Models) : Single-centre, Open Label, Single Arm, Feasibility Test
Status: Enrolling
Updated:  10/11/2017
Pusan National University Yangsan Hospital
mi
from
Yangsan,
Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation
The Study on Safety and Feasibility of Mitral Loop Cerclage(MLC) Annuloplasty Procedure With Investigational Medical Device (MLC-B-45-75-R and Other 11 Models) : Single-centre, Open Label, Single Arm, Feasibility Test
Status: Enrolling
Updated: 10/11/2017
Pusan National University Yangsan Hospital
mi
from
Yangsan,
Click here to add this to my saved trials
BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI
Functional Magnetic Resonance Angiographic Imaging Using Blood Oxygen Level Determination (BOLD) Assessment as a Surrogate of Improved Skeletal Muscle Oxygenation After Endovascular Therapy for the Treatment of Chronic Lower Limb Ischemia
Status: Enrolling
Updated:  10/11/2017
St. Johns Hospital
mi
from
Springfield, IL
BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI
Functional Magnetic Resonance Angiographic Imaging Using Blood Oxygen Level Determination (BOLD) Assessment as a Surrogate of Improved Skeletal Muscle Oxygenation After Endovascular Therapy for the Treatment of Chronic Lower Limb Ischemia
Status: Enrolling
Updated: 10/11/2017
St. Johns Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Arizona Heart Institute
mi
from
Phoenix, AZ
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Arizona Heart Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Central Arkansas Veteran's Hospital
mi
from
Little Rock, AR
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Central Arkansas Veteran's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Long Beach VA Healthcare System
mi
from
Long Beach, CA
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Long Beach VA Healthcare System
mi
from
Long Beach, CA
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
University of Southern California Healthcare Consultation Ctr. II
mi
from
Los Angeles, CA
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
University of Southern California Healthcare Consultation Ctr. II
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
West Los Angeles VA Medical Centre
mi
from
Los Angeles, CA
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
West Los Angeles VA Medical Centre
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Kaiser Permanente Hospital
mi
from
San Francisco, CA
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Kaiser Permanente Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Florida Vascular Consultants
mi
from
Maitland, FL
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Florida Vascular Consultants
mi
from
Maitland, FL
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Miller School of Medicine University of Miami
mi
from
Miami, FL
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Miller School of Medicine University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Southern Illinois Univ. School of Med.
mi
from
Springfield, IL
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Southern Illinois Univ. School of Med.
mi
from
Springfield, IL
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Indiana University Vascular Surgery, Methodist Hospital
mi
from
Indianapolis, IN
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Indiana University Vascular Surgery, Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Massachusetts General Hospital Vascular and Endovascular Surgery
mi
from
Boston, MA
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Massachusetts General Hospital Vascular and Endovascular Surgery
mi
from
Boston, MA
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Michigan Vascular Research Center
mi
from
Flint, MI
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Michigan Vascular Research Center
mi
from
Flint, MI
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
University of Medicine & Dentistry NJ
mi
from
New Brunswick, NJ
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
University of Medicine & Dentistry NJ
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Center for Vascular Awareness, Inc.
mi
from
Albany, NY
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Center for Vascular Awareness, Inc.
mi
from
Albany, NY
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
University of Buffalo Surgeons Inc.
mi
from
Buffalo, NY
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
University of Buffalo Surgeons Inc.
mi
from
Buffalo, NY
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Oregon Health and Science University
mi
from
Portland, OR
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Vascular and Transplant Specialist
mi
from
Norfolk, VA
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Vascular and Transplant Specialist
mi
from
Norfolk, VA
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
Peter Lougheed Center
mi
from
Calgary,
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
Peter Lougheed Center
mi
from
Calgary,
Click here to add this to my saved trials
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated:  10/12/2017
University of Florida
mi
from
Gainesville, FL
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Status: Enrolling
Updated: 10/12/2017
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Optimizing Health Outcomes in Patients With Symptomatic Aortic Valve Disease
Optimizing Health Outcomes in Patients With Symptomatic Aortic Valve Disease
Status: Enrolling
Updated:  10/12/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Optimizing Health Outcomes in Patients With Symptomatic Aortic Valve Disease
Optimizing Health Outcomes in Patients With Symptomatic Aortic Valve Disease
Status: Enrolling
Updated: 10/12/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy
Pure-Heart-1: A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy
Status: Enrolling
Updated:  10/12/2017
Boston Children's Hospital
mi
from
Boston, MA
A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy
Pure-Heart-1: A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy
Status: Enrolling
Updated: 10/12/2017
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Ninvasive Cardiac Output Measurements During Cesarean Delivery Under Spinal Anesthesia.
To Determine if the Cardiac Output Monitoring During Cesarean Delivery Under Spinal Anesthesia Will Change Our Clinical Practice of Using Vasopressors
Status: Enrolling
Updated:  10/13/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Ninvasive Cardiac Output Measurements During Cesarean Delivery Under Spinal Anesthesia.
To Determine if the Cardiac Output Monitoring During Cesarean Delivery Under Spinal Anesthesia Will Change Our Clinical Practice of Using Vasopressors
Status: Enrolling
Updated: 10/13/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Improving Functional Capacity in Fontan Patients Through Inspiratory Muscle Training
Improving Functional Capacity in Fontan Patients Through Inspiratory Muscle Training
Status: Enrolling
Updated:  10/14/2017
Children's Hospital Boston
mi
from
Boston, MA
Improving Functional Capacity in Fontan Patients Through Inspiratory Muscle Training
Improving Functional Capacity in Fontan Patients Through Inspiratory Muscle Training
Status: Enrolling
Updated: 10/14/2017
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
Status: Enrolling
Updated:  10/16/2017
Massachusetts General Hospital
mi
from
Boston, MA
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
Status: Enrolling
Updated: 10/16/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated:  10/17/2017
Alaska Heart Institute
mi
from
Anchorage, AK
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated: 10/17/2017
Alaska Heart Institute
mi
from
Anchorage, AK
Click here to add this to my saved trials
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated:  10/17/2017
Palo Alto Medical Foundation
mi
from
Palo Alto, CA
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated: 10/17/2017
Palo Alto Medical Foundation
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated:  10/17/2017
Minneapolis Heart Institute Foundation
mi
from
Minneapolis, MN
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated: 10/17/2017
Minneapolis Heart Institute Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated:  10/17/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated: 10/17/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated:  10/17/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated: 10/17/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated:  10/17/2017
West Penn Allegheny Health System
mi
from
Pittsburgh, PA
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated: 10/17/2017
West Penn Allegheny Health System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated:  10/17/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Diagnostic Investigation of Sudden Cardiac Event Risk
Identifying Markers That Predict Ventricular Arrhythmia Risk
Status: Enrolling
Updated: 10/17/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials